NDC 70518-0050-00 - Furosemide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-0050
- Requested NDC
- 70518-0050-00
- Package NDCs from labels
- 70518-0050-0, 70518-0050-1, 70518-0050-2, 70518-0050-3, 70518-0050-4, 70518-0050-00
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-09-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg | REMEDYREPACK INC. | 2026-09-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-0050-0 | Furosemide | 30 in 1 BLISTER PACK | TABLET | 30 | 25 | |
| 70518-0050-1 | Furosemide | 90 in 1 BOTTLE | TABLET | 90 | 25 | |
| 70518-0050-2 | Furosemide | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 25 | |
| 70518-0050-3 | Furosemide | 180 in 1 BOTTLE, PLASTIC | TABLET | 180 | 25 | |
| 70518-0050-4 | Furosemide | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 25 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-0050 | FUROSEMIDE (FUROSEMIDE) TABLET [REMEDYREPACK INC.] | 22 | Current NDC, Legacy NDC, 5 package rows | 20250529_571a52ed-5258-46d5-a0d2-9a984cf73895.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Furosemide | FUROSEMIDE | Micro Labs Limited | 2f547f7c-0322-465c-9764-43f955d98ab2 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Henry Schein, Inc. | d8407b0e-7838-4ab6-b9dd-1f7ecf1e0a17 | 2026-10-30 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| FUROSEMIDE | FUROSEMIDE | Henry Schein, Inc. | a9853417-0442-4f53-9543-e0749bc3c80d | 2026-10-30 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| FUROSEMIDE | FUROSEMIDE | Henry Schein, Inc. | 15e4c3a3-7d64-471e-bfdf-6156731e24aa | 2026-10-30 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 668e9f1f-0df0-45f6-8281-f1b98a4a681d | 2026-10-29 | Warnings, Adverse reactions | 197732 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Cardinal Health 107, LLC | d75ba8bd-9494-4306-8443-9c1a90992dd5 | 2026-10-26 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| FUROSEMIDE | FUROSEMIDE | HF Acquisition Co LLC, DBA HealthFirst | 5e37f97b-f5db-23a0-e063-6394a90a9b72 | 2026-10-19 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| FUROSEMIDE | FUROSEMIDE | HF Acquisition Co LLC, DBA HealthFirst | 5e38ad23-ac84-e936-e063-6394a90ae351 | 2026-10-19 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 48d8f490-e9d1-4c95-ab2f-414d3f4a9df4 | 2026-10-16 | Warnings, Adverse reactions | 313988 7LXU5N7ZO5 |
| FUROSEMIDE | FUROSEMIDE | Cardinal Health 107, LLC | 2590ebb6-ce2a-4e23-9244-e54e3010d488 | 2026-10-15 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | c24489c3-65e0-44e3-a50a-8bb0672e8821 | 2026-10-14 | Warnings, Adverse reactions | 310429 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 52e75604-5766-40e8-a13a-8c449e06ebda | 2026-10-14 | Warnings, Adverse reactions | 313988 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 12137a90-fb35-45d7-8984-0b04793d3e34 | 2026-10-14 | Warnings, Adverse reactions | 197732 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Amneal Pharmaceuticals LLC | d5b9f12e-d1e9-42de-90f2-c9ba33a86457 | 2026-09-17 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Lymph Tonic II | ECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANA | BioActive Nutritional, Inc. | 0e3265b0-b210-4a4c-80d2-8a9712981d4e | 2026-09-17 | Warnings | ETJ7Z6XBU4 |
| Furosemide | FUROSEMIDE | REMEDYREPACK INC. | 571a52ed-5258-46d5-a0d2-9a984cf73895 | 2026-09-15 | Warnings, Adverse reactions | ANDA077293 70518-0050-2 70518-0050-0 70518-0050-1 70518-0050-4 70518-0050-3 70518-0050 70518005000 310429 5b8b784a-7602-396b-e063-6294a90a5d8c 571a52ed-5258-46d5-a0d2-9a984cf73895 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | NuCare Pharmaceuticals,Inc. | 0b3d986c-eecc-adbe-e063-6294a90a0fb2 | 2026-09-14 | Warnings, Adverse reactions | 313988 7LXU5N7ZO5 |
| FUROSEMIDE | FUROSEMIDE | REMEDYREPACK INC. | ab1a7e16-f746-41af-8faf-b69d3ffd62ba | 2026-09-11 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Psoriasis Control | CENTELLA ASIATICA, SODIUM CHLORIDE, AND SILICON DIOXIDE | Forces of Nature | 2db33771-0bb9-49f8-84fa-dddc28e4ba26 | 2026-09-04 | Warnings | ETJ7Z6XBU4 |
| BMNP Silicea | SILICEA | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5a58454f-aed6-24ba-e063-6294a90a47fb | 2026-08-31 | Warnings | ETJ7Z6XBU4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.